SYMLIN� Market OpportunityUnited States
Source: ADA, CDC, Amylin internal data for 2001
TOTAL Diabetes US: 17.5 million people
~6% growth per year
(3x population growth)
Orals
5.9 M
Not Diagnosed
6.0 M
Insulin
4.5 M
Diet
1.1 M
Previous slide
Next slide
Back to first slide
View graphic version